Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $620.6900 (1.33%) ($614.2100 - $627.9900) on Mon. Aug. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.37% (three month average) | RSI | 44 | Latest Price | $620.6900(1.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.4% a day on average for past five trading days. | Weekly Trend | REGN declines -1.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) SPLV(39%) IVW(38%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -1.185% in a week (0% probabilities). VIXM(-21%) VXX(-7%) UUP(-7%) TBT(-6%) DRIV(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.185% (StdDev 2.37%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $611.86(-1.42%) | Resistance Level | $624.54 | 5 Day Moving Average | $611.2(1.55%) | 10 Day Moving Average | $617.3(0.55%) | 20 Day Moving Average | $624.54(-0.62%) | To recent high | -5.7% | To recent low | 14.1% | Market Cap | $65.811b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |